May - 2018
| Previous Next | Showing Journal 4 of 7 |
Low-Dose Nocturnal Dexmedetomidine Prevents ICU DeliriumY Skrobik, M Duprey, N Hill, J Devlin Am J Resp Crit Care Med, 2018, 197(9);1147-1156 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
May |
Previous Comments
No Comments yet.
Comment
The intersection between sleep, sedation, critical illness and delirium remains important and unsolved. Could dexmedetomidine, used as a nocturnal agent, improve sleep and reduce delirium?
This prospective phase II RCT;
...